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Introduction
Skeletal muscle adapts to environmental changes and 
differing levels of physical activity. Periods of disuse, where 
prolonged reductions in muscle activity and mechanical 
loading occur, result in profound changes in skeletal muscle 
morphology and strength in addition to bone parameters. 
It has consistently been demonstrated, that disuse models, 
including immobilisation, bed-rest and limb-suspension 
result in skeletal muscle atrophy (1-3), a decrease in maximal 
voluntary strength (1-3), and changes in electromyographic 
characteristics (4). Numerous studies have also documented the 
effects of immobilisation models on muscle fatigability, with 
equivocal findings of both decreased, increased and no change 
in resistance to fatigue (3, 5, 6). With progressing fatigue, there 
is a shift in electromyography (EMG) to lower frequencies, 
and median power frequency can be used as an indices of this 
frequency shift. A decrease in the median power frequency 
serves as an index of fatigue (7, 8). Fast Fourier transform 
(FFT) of EMG produces a discrete-time, discrete-frequency 
representation and can be used to determine median power 
frequency. There are also several reports of the impact of disuse 
on the cardiovascular system with reports of decreased reactive 
hyperaemic blood flow (9-11). Early research demonstrated 
that static muscular contractions were accompanied by a 
marked impairment in blood flow to exercising muscles (12). 
Since then impaired blood flow has been used as an explanation 
for muscle fatigue during isometric contractions. Local changes 
in vascular dimensions and blood flow characteristics have 
been shown in response to resistance training, with de-training 
resulting in a worsening in theses parameters (beyond pre-
training values) (13). Therefore, decreased loading with disuse, 
may negatively impact on vascular structure and function.
The ever-increasing population of frail elderly puts a 
strain on healthcare services. Indeed, prolonged sedentarism/
hypo-activity as may be encountered in enforced bed rest, 
immobilisation owing to orthopaedic clinic events, or simply 
even, decreased habitual physical activity, all show a high 
incidence in older persons (14-18). A common and serious 
problem for older adults is falls, with polypharmacy and 
some medications contributing to falls in many patients (19). 
This factor however, is remediable and non-pharmacological 
interventions are needed to prevent the age-associated loss in 
muscle size and function. Exercise could be beneficial in these 
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circumstances but is not always a practical prescription; and as 
such, nutritional interventions could be key.
Vitamin D is required to absorb calcium and phosphorus in 
the body and has been shown to have a direct effect on muscle 
(20). Vitamin D plays a vital role in bone maintenance, muscle 
function, neuromuscular and immune functions, modulation of 
cell growth and reduction of inflammation. The main source of 
vitamin D is from sunlight on the skin, with smaller amounts 
consumed in certain foods. Another way of making sure that 
the Recommended Dietary Allowance for vitamin D of 600 
IU/day (21) is met, is through vitamin D supplementation. 
Research has demonstrated that vitamin D impacts on both the 
trans-membranous flows of calcium and phosphate in skeletal 
muscle, and the synthesis rate of contractile properties (22). 
Furthermore, research has indicated an association between 
genetic variation in the vitamin D receptor gene and muscle 
strength, fat mass and body mass in premenopausal women 
(23). Vitamin D supplementation in frail elderly women with 
vitamin D deficiency reduced falls by 49% and improved 
musculoskeletal function (24). It remains to be seen, in a 
healthy population with no known vitamin D deficiency, 
whether vitamin D supplementation would positively affect 
the response of muscle structural and contractile properties to 
immobilisation.
Another non-pharmacological agent that may help attenuate 
the changes associated with immobilisation is Eicosapentaenoic 
acid (EPA). EPA is an n-3 polyunsaturated fatty acid with anti-
inflammatory properties, which is synthesised from ingested 
alpha-linolenic acid or consumed in fish or in fish oil. Adequate 
intake (AI) for EPA is set at  1.6 and 1.1 g/day for men and 
women, respectively (25). Magee et al. suggested that EPA 
might reduce the pro-inflammatory cytokines associated with 
inflammation (26). They demonstrated in vitro that EPA 
inhibits the effects of TNF-α by reducing its apoptotic effects 
and enabling myogenesis (26). Previous research has suggested 
the potential of EPA to increase isometric and isokinetic 
torque (27). It is unclear whether this supplement would have 
a beneficial effect during immobilisation, where it is generally 
accepted that there is muscle atrophy (28), which is associated 
with decreased protein synthesis (29), but scant evidence for 
increased protein breakdown (30).
As described in Part A (i.e. our previous study), an arm 
immobilisation model was chosen as it is relatively less 
restraining on daily life and causes less burden on participants. 
In Part A, whilst there was no significant effect of supplement 
group on muscle size decreases with immobilisation, a non-
significant trend for lesser atrophy in the treatment groups was 
seen. Based on the greater decline in muscle strength (due to 
the combined effects of neural and muscle components) with 
disuse, it is possible that functional measures are more sensitive 
to immobilisation than structural changes. Thus, it is possible, 
that EPA and vitamin D may preserve muscle function to a 
greater extent than a placebo over the period of immobilisation. 
The research question, therefore, was: what role, if any, 
have vitamin D or EPA supplementation in attenuating the 
changes associated with limb immobilisation? To answer this 
research question, isometric and isokinetic torque, agonist 
co-contraction, muscle fatigability and resting arterial blood 
flow markers, were systematically monitored, immediately 
post-immobilisation and post-remobilisation, to compare 
against status pre-immobilisation. Study participants received 
either ω-3 (a fish oil of a complex of EPA and docosahexaenoic 
acid (DHA)), vitamin D or a placebo (Lecithin). Hereafter, 
these agents are simply referred to as EPA, vitamin D or 
placebo supplementation. It was hypothesised that muscle 
function will decrease, muscle co-contraction characteristics 
will worsen, and indices of healthy vascular function will 
deteriorate, with limb immobilisation. It was also hypothesised 
that EPA would be the most successful supplement at 
minimising these changes, as it acts on the protein synthesis 
pathways.
Methods
Participants & Study Design
Participant inclusion and criteria were as described in study 
Part A. Briefly, twenty-four healthy volunteers participated 
in the study, following appropriate ethical approval, and then 
randomly assigned to one of three groups (PLA: n = 8 (6 
females, 2 males); EPA: n = 8 (4 females, 4 males); Vit-D: 
n = 8 (5 females, 3 males)).  The study used a randomised, 
double-blind, placebo-controlled design with the placebo group 
consuming 1464 mg Soya Lecithin (Holland & Barrett, UK) 
daily, the Vit-D group consuming 1,000 IU of Vitamin D3 
(Now Foods Bloomingdale, U.S.A.) daily, and the EPA group 
consuming 1770 mg EPA plus 390 mg docosahexenoic acid 
(MorEPA, Minami Nutrition, UK), daily. 
Participants attended a familiarisation session at least one 
week prior to the first testing session. After baseline testing, the 
non-dominant arm was immobilised in a sling for a minimum 
of nine waking hours a day for two continuous weeks. The 
correct sling wearing procedure was demonstrated to each 
participant (Figure 1 of Part A), the removal of the sling was 
only permitted when necessary (e.g. driving, taking a bath/
shower etc.). The sling minimised any movement medio-
laterally at the elbow and shoulder and participants were 
required to not contract the upper musculature (including the 
hands) during immobilisation hours. Measures of isometric 
and isokinetic elbow torque, EMG co-contraction, muscle 
fatigability and arterial dimensions and blood flow, were 
taken immediately before the immobilisation period (Pre), 
immediately after the immobilisation period (Post), and two 
weeks after remobilisation (Post2). During the immobilisation 
period participants completed a 3-day food diary, a daily 
activity log (including sling-wear hours) and wore a pedometer 
(Omron Walking style III step counter, Omron Healthcare 
Co., Ltd, Kyoto, Japan) to record the number of steps taken 
each day. The food diaries were analysed for macronutrient 
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and micronutrient average intake using Microdiet Plus 1.2 
(Microdiet, Downlee Systems Ltd, UK). Nutritional 
information and steps taken each day are reported in the results 
section of Part A.
Dynamometry
Isometric and isokinetic elbow torque were assessed using 
a Cybex dynamometer (Cybex, New York, USA). Participants 
were positioned as per the manufacturer’s recommendations. 
Briefly, they were positioned in a supine position with the axis 
of rotation of the dynamometer aligned with the anatomical 
axis of rotation of the elbow joint (lateral epicondyle). 
Isometric dynamometry
Following a warm up at 60°/sec at the participant’s self-
perceived ~75% of maximum effort, two repetitions of 
isometric contractions were performed at six different elbow 
joint angles (60°, 70°, 80°, 90°, 100° and 110°), 60 seconds 
apart. Participants were instructed to rapidly exert maximal 
torque against the dynamometer lever arm over a 3-4 second 
period. First in flexion and, five seconds after return to 
baseline, in extension. Torque and angle were displayed on 
the screen of a computer (Macintosh G4; Apple Computer, 
Cupertino, CA), which was interfaced with an A/D system 
(Acknowledge, Biopac Systems, Santa Barbara, CA) with a 
sample frequency of 200 Hz. Participants were encouraged 
to exert maximal torque with the use of visual and verbal 
feedback. Peak torque was averaged over a 500 ms period (i.e. 
250 ms either side of the instantaneous peak). The highest of 
the repeated efforts was used as the participant’s measure of 
MVC at each angle for elbow flexion and extension.
Isokinetic dynamometry
Isokinetic contractions were completed with three 
continuous elbow extensions and flexions at six different 
speeds (30, 60, 90, 120, 180 and 240°/sec) separated by 90 
seconds, in a randomised order. The highest of the three 
consecutive efforts was recorded as peak torque (25 ms either 
side of the instantaneous peak) for elbow extension and flexion 
at each speed.
Electromyographic measurements
Muscle activation patterns were assessed using EMG 
during the isometric and isokinetic contractions. The skin was 
prepared by shaving, abrading and cleaning with an alcohol-
wipe to minimise resistance below 5 kΩ (31). Self-adhesive 
electrodes were placed in pairs either side of the marker of 
a third of the distance along the biceps and triceps brachii, 
with reference electrodes placed on the lateral and medial 
epicondyle of the humerus. Raw EMG data were recorded at 
2000 Hz, with a band pass filter set at 10-500 Hz, and a notch 
set at 50 Hz (Biopac Systems). Biceps co-contraction was 
calculated (biceps EMG during extension / biceps EMG during 
flexion) for both isometric and isokinetic contractions. Triceps 
co-contraction was also calculated (triceps EMG during flexion 
/ triceps EMG during extension) again for both isometric and 
isokinetic contractions. Biceps and triceps EMG values were 
taken during the same windows as in isometric and isokinetic 
torque.
Fatiguing contractions
The dynamometer lever arm was locked at a 90° angle 
(where 180° is full elbow extension) and participants were 
required to exert a maximal isometric contraction in the 
direction of elbow flexion for 30 seconds. After 90 seconds of 
recovery, the participant then repeated the maximal isometric 
contraction for 30 seconds, this time in the direction of elbow 
extension. The mean, slope and standard deviation of the 
torque trace were recorded for the length of the 30-second 
contractions. FFT was computed for the agonist muscle during 
the first five and last five seconds of each fatiguing contraction. 
Median frequency values were determined for these time points 
and a change in median frequency was then computed as a 
measure of the fatigability of the muscle.
Arterial resting blood flow
After more than 20 minutes seated rest (following muscle 
ultrasound scans), allowing for the regulation of vascular 
tone, measurements in the sagittal plane of resting brachial 
artery diameter, heart rate (HR), resistance index (RI) and 
flow by diameter (FbD) were obtained from the ultrasound 
software. The measurements were obtained using an echo 
Doppler ultrasound machine (AU5, Esaote, Genoa, Italy) with a 
5.0- 13.0 MHz broadband linear array transducer (with settings 
of Doppler gain 37-41, angle of insonnation 60 degrees). The 
ultrasound probe was applied to the arm in line with the marker 
of the midpoint of the biceps brachii (as previously marked 
earlier for obtaining muscle ultrasound images). An average of 
nine cardiac cycles were acquired for all measurements, with 
the mean value reported.
Statistics
Data were analysed using IBM SPSS v21 (IBM Inc, USA). 
The Shapiro-Wilk test revealed some of the data to be non-
parametric (EMG, fatigue, brachial artery diameter, HR and 
FbD values). The effect of immobilisation was examined by 
assessing the changes seen in the PLA group by either repeated 
measures ANOVA (parametric data) or a Friedman test (non-
parametric data). Parametric percentage change values (Pre-
to-Post: (Post-Pre)/Pre; and Pre-to-Post2: (Post2-Pre)/Pre) 
were analysed using a repeated measures ANOVA, with post-
hoc Bonferonni corrected 2-tailed t-tests to determine group 
difference. Non-parametric between group effect were analysed 
using the Kruskal Wallis test, with post-hoc the Mann-Whitney 
U tests. All data are presented as mean ± standard deviation 
(SD). Statistical significance was set with alpha at ≤ 0.05.
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There were no significant differences in baseline 
characteristics (Table 1 of series A). Additionally, the groups 
did not differ in baseline isometric MVC elbow torque (e.g. 
isometric elbow torque at 90° for flexion - PLA: 37.6 ± 15.0 
Nm; EPA: 42.0 ± 15.7 Nm; Vit-D: 42.3 ± 13.7 Nm) EMG and 
fatigue values, or resting arterial blood vessel characteristics 
(vessel diameter - PLA: 3.3 ± 0.5 mm; EPA: 3.3 ± 0.6 mm; 
Vit-D: 3.2 ± 0.3 mm, HR – PLA: 69.6 ± 11.6 bpm; EPA: 68.5 
± 12.1 bpm; Vit-D: 69.1 ± 6.7 bpm, RI – PLA: 0.7 ± 0.3; EPA: 
0.8 ± 0.1; Vit-D: 0.9 ± 0.1, FbD – PLA: 0.11 ± 0.05 m/s; EPA: 
0.07 ± 0.02 m/s; Vit-D: 0.06 ± 0.03 m/s).
Isometric dynamometry
Isometric MVC torque decreased for both elbow flexion and 
extension at every angle (p<0.05) except for flexion at 110° and 
extension at 100° and 110°. Average isometric torque decrease 
from Pre to Post immobilisation across angles for flexion were 
12.1 ± 1.8 %, 11.4 ± 3.5 % and 8.1 ± 3.4 %, and for extension 
were 15.4 ± 3.3 %, 12.0 ± 3.1 % and 10.7 ± 2.4 %, for PLA, 
EPA and Vit-D, respectively. There was no effect of group 
on the percentage change in isometric torque for flexion or 
extension at any of the six angles (Figure 1). 
Figure 1
Isometric torque changes in response to immobilisation and 
supplementation
Pre (circles), Post (squares) and Post2 (triangles) values for isometric torque (Nm ± SD) 
for elbow flexion (a = PLA; b = EPA; c = Vit-D) and elbow extension (d = PLA; e = EPA; 
f = Vit-D) at the six different angles (60-110°). * Significant difference between Pre and 
Post immobilisation in the PLA group.
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Table 1




Mean Torque (Nm) Pre 26.2 ± 12.7 27.1 ± 11.3 28.4 ± 10.8
Post 24.5 ± 12.1 23.6 ± 10.0 26.8 ± 10.9
Post2 25.8 ± 12.1 24.7 ± 8.9 26.8 ± 11.4
Flexion
Standard Deviation Pre 3.2 ± 1.4 3.4 ± 1.3 3.0 ± 1.3
Post 2.7 ± 0.8 2.9 ± 1.4 3.5 ± 1.7
Post2 3.3 ± 1.3 2.7 ± 1.3 3.5 ± 1.7
Flexion
Slope Pre -0.3 ± 0.2 -0.2 ± 0.1 -0.2 ± 0.1
Post -0.3 ± 0.2 -0.2 ± 0.1 -0.3 ± 0.2
Post2 -0.3 ± 0.2 -0.1 ± 0.1 -0.1 ± 0.1
Flexion
Agonist FFT
1st Five Seconds (Hz) Pre 113.6 ± 22.6 102.9 ± 8.5 102.3 ± 5.3
Post 116.5 ±13.5 106.5 ± 7.8 103.9 ± 5.1
Post2 112.1 ± 17.3 103.7 ± 8.0 102.1 ± 4.7
Flexion
Agonist FFT
Last Five Seconds (Hz) Pre 115.2 ± 16.7 102.1 ± 8.0 104.2 ± 9.5
Post 119.1 ± 15.8 105.5 ± 5.3 105.6 ± 8.5
Post2 113.6 ± 12.7 101.8 ± 8.3 104.2 ± 9.2
Extension
Mean Torque (Nm) Pre 20.4 ± 14.4 23.8 ± 11.8 21.9 ± 12.1
Post 19.2 ± 13.5 19.2 ± 8.7 17.7 ± 10.2
Post2 21.3 ± 12.1 22.5 ± 10.7 22.3 ± 9.6
Extension
Standard Deviation Pre 2.9 ± 1.9 2.4 ± 1.6 2.2 ± 1.3
Post 2.5 ± 1.5 2.5 ± 1.4 2.1 ± 0.9
Post2 2.8 ± 2.1 2.2 ± 1.4 2.1 ± 1.1
Extension
Slope Pre -0.3 ± 0.6 0.1 ± 0.1 -0.2 ± 0.3
Post -0.2 ± 0.2 -0.1 ± 0.2 -0.2 ± 0.2
Post2 -0.3 ± 0.4 -0.1 ± 0.3 -0.1 ± 0.1
Flexion
Agonist FFT
1st Five Seconds (Hz) Pre 131.8 ± 13.6 128.9 ± 13.3 131.5 ± 9.7
Post 132.6 ± 16.5 130.3 ± 12.0 133.2 ± 13.2
Post2 142.3 ± 15.8 130.1 ± 14.4 131.7 ± 9.9
Flexion
Agonist FFT
Last Five Seconds (Hz) Pre 124.7 ± 17.0 124.1 ± 16.0 127.7 ± 12.4
Post 125.0 ± 19.3 125.7 ± 15.3 129.4 ± 13.7
Post2 124.3 ± 18.6 125.1 ± 15.9 128.5 ± 12.4
Mean values ± SD for fatigue characteristics. The response of both the torque trace 
and fast Fourier transform of the agonist muscle during both a 30 second elbow flexion 
maximal fatiguing contraction and a 30 second elbow extension fatiguing contraction.
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Isokinetic dynamometry
Isokinetic torque decreased significantly for both elbow 
flexion and extension at every speed (p<0.05) except for 
flexion at 90°/sec. Average isokinetic torque decrease from 
Pre to Post immobilisation across speeds for flexion were 14.0 
± 4.5 %, 8.6 ± 1.3 % and 7.8 ± 5.5 %, and for extension were 
10.3 ± 1.8 %, 8.1 ± 0.9 % and 7.1 ± 1.8 %, for PLA, EPA and 
Vit-D, respectively. There was no effect of supplement group 
on the percentage change in isokinetic torque for flexion or 
extension at any of the six speeds. (Figure 2) 
Figure 2
Isokinetic torque changes in response to immobilisation and 
supplementation
Pre (circles), Post (squares) and Post2 (triangles) values for isokinetic torque (Nm ± SD) 
for elbow flexion (a = PLA; b = EPA; c = Vit-D) and elbow extension (d = PLA; e = EPA; 
f = Vit-D) at the six different speeds (30-240°/sec). * Significant difference between Pre 
and Post immobilisation in the PLA group.
Electromyographic measurements
Analysis of biceps and triceps co-contraction RMS EMG 
values during the isometric contractions showed no significant 
changes from Pre to Post immobilisation and no effect of 
supplement group from Pre-to-Post and Pre-to-Post2 (Figure 3). 
Similarly, this was the case for the isokinetic contractions with 
no significant effect of immobilisation nor of supplement group 
on the EMG response to the immobilisation (Figure 4).
Fatiguing contractions
The mean, slope and standard deviation of the torque 
traces showed no significant changes with immobilisation 
phase for either flexion or extension fatiguing contractions, 
with no effect of supplement group on percentage changes. 
Analysis of the fast Fourier transformation of EMG traces of 
the biceps and triceps brachii revealed no significant effect 
of immobilisation or supplementation group on rate coding 
at either the beginning, or the end of a fatiguing maximal 
isometric contraction (Table 1).
Figure 3
Isometric bicep and triceps co-contraction changes in response 
to immobilisation and supplementation
Pre (circles), Post (squares) and Post2 (triangles) values for co-contraction (Nm ± SD) 
of the biceps (a = PLA; b = EPA; c = Vit-D) and triceps (d = PLA; e = EPA; f = Vit-D) 
during isometric elbow flexion and extension at the six different angles (60-110°).
Arterial resting blood flow
Brachial artery diameter, RI, FbD and HR did not change 
from Pre to Post immobilisation, nor Pre to Post2. There was 
no significant difference in the percentage change in brachial 
artery diameter, RI, FbD or HR between the groups (Table 2).
Measurement reliability
All protocols were assessed for intra as well as inter-day 
reliability. This utilised five participants and entailed carrying 
out measurements three times on day 1, and repeating these on 
day 2, approximately a week later. Within-day coefficients of 
variation (CV) of 1.8 %, 2.0 %, 1.5 %, 5.4 %, 2.4 % and 12.0 
%, and between-day CVs of 2.5 %, 2.3 %, 2.3 %, 8.1 %, 4.0 % 
and 9.1 % were yielded for isometric torque, isokinetic torque, 
brachial artery diameter, HR, RI and FbD, respectively.
Discussion
We describe the effects of two potential protein-sparing 
modulators (EPA of vitamin D supplementations) on the 
response to 2 weeks of 9-waking-hours-per-day combined 
arm and shoulder immobilisation. We hypothesised that 
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muscle function will decrease and muscle co-contraction 
characteristics will increase, and indices of healthy vascular 
function will deteriorate, with limb immobilisation. We found 
evidence to partially support our hypotheses, with significant 
immobilisation-induced decreases in isometric elbow flexion 
(PLA: 6.7 to 18.4%) and extension (PLA: 8.7 to 13.8%) torque, 
as well as isokinetic elbow flexion (PLA: 9.3 to 13.7%) and 
extension (PLA: 9.8 to 18.1%) torque. It was also hypothesised 
that EPA would be the most effective supplement at minimising 
the response to immobilisation. Our data demonstrate that 
neither EPA nor vitamin D had any significant effect on the 
responses to non-injurious immobilisation. Nonetheless, a few 
trends towards the attenuation of elbow isometric and isokinetic 
torque immobilisation-induced decreases were observed, in 
the EPA and Vit-D treated groups. We discuss the observed 
trends for the attenuation of these parameters. It is also notable 
that this immobilisation model had no impact on the assessed 
co-contraction and muscle fatigability, or on the assessed blood 
flow characteristics.
Figure 4
Isokinetic bicep and triceps co-contraction changes in response 
to immobilisation and supplementation
Pre (circles), Post (squares) and Post2 (triangles) values for co-contraction (Nm ± SD) 
of the biceps (a = PLA; b = EPA; c = Vit-D) and triceps (d = PLA; e = EPA; f = Vit-D) 
during isokinetic elbow flexion and extension at the six different speeds (30-240°/sec).
Isometric elbow extensor and flexor torque decreased 
following immobilisation. This supports previous findings 
of decreases in isometric MVC of the elbow flexors 
in response to 4 weeks of elbow cast immobilisation (6). 
In addition to the established decline in isometric torque, 
disuse models also result in reductions in dynamic torque 
outputs. Cast immobilisation of the arm (9 days) also results 
in decreased concentric and eccentric strength for flexion 
and extension of the wrist (3). Our current data also show 
a decrease in isokinetic strength for both elbow flexion and 
extension. However, muscle function in terms of isometric and/
or isokinetic torque, did not show a significant effect of either 
EPA or vitamin D supplementation at the current doses, in 
spite of somewhat blunting the effect of immobilisation, as this 
protective effect was not statistically significant.
Data collected for agonist and antagonist EMG activity 
highlighted no differences in biceps or triceps co-contraction 
following immobilisation. In contrasting, some of the 
previous research shows a large decrease in EMG amplitude 
measurements during flexion in both the agonist and antagonist 
muscle (4, 6). When drawing conclusions from EMG findings 
care should be taken, as: 1) the changes in muscle dimensions 
could result in a different population of motor units being 
recorded from (32); 2) EMG reliability in previously published 
studies is not very high, and this is a general limitation of 
studies utilising longitudinal EMG monitoring (33, 34). In 
addition, it is notable that EMG data in our, and previous work 
(31), does not normalise the data for the clarity of the signal. 
Specifically, we have recently demonstrated that sub-cutaneous 
adiposity changes with immobilisation (see study Part A of our 
current work), hence the electromyographic signature would 
have differed (35).
Numerous studies have documented the effects of 
immobilisation models on muscle fatigability, with equivocal 
findings of both decreased, increased and no change in 
resistance to fatigue (3, 5, 6). In our current study, we found 
no significant changes in the mean, slope or standard deviation 
of the torque trace during the 30s isometric contraction fatigue 
tasks that we implemented. Differences between studies could 
be due to the mode/duration of disuse or in the method used 
to test fatigue resistance since fibre recruitment level and 
pattern would vary with changes in contractile profile (36). 
The mechanisms behind the varying effects of immobilisation 
on muscle fatigability are yet to be fully explained. Our 
observation of no significant effect of immobilisation on 
the fast Fourier transformation of EMG traces at either the 
beginning or end of a maximal isometric contraction suggests 
no effect on motor unit rate coding and none on fibre type 
recruitment.
Previous research suggests that decreases in physical 
activity leads to detrimental vascular adaptations (37, 38). 
Bed-rest studies measuring leg blood flow report inconsistent 
results, with some showing no changes in leg blood flow 
and others demonstrating a decrease in leg blood flow after 
periods of bed rest (10-41 days) (38-41). None of these 
bed rest studies report data on changes in arterial vessel 
diameter. Studies investigating vascular changes in response 
to upper limb immobilisation are lacking. We report no 
significant dimensional changes in vasculature with upper 
limb immobilisation. Similarly, we observed no significant 
changes in resting HR in response to immobilisation. Equally, 
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our assessment of resting arterial blood flow (diameter, RI 
and FbD) revealed no significant changes in response to 
immobilisation; however, we report resting and not reactive 
blood flow and as such were less likely to see any effect 
(11). The lack of change in muscle fatigability, however, 
goes hand in hand with the absence of vascularisation-related 
alterations. Recently, higher circulating concentrations 
of 1,25-dihydroxyvitamin D have been associated with a 
higher risk of hypertension (42). The authors suggested that 
the vitamin D-induced increase in calcium absorption could 
promote vascular calcification, which in turn could lead to 
increased arterial stiffness and greater hypertension risk. In the 
current study, vitamin D supplementation did not impact on the 
measured resting arterial blood flow parameters, however, in 
the current study this was a short duration supplementation that 
may not have resulted in comparable increases in circulating 
concentrations of 1,25-dihydroxyvitamin D. The lack of impact 
of EPA supplementation on the measured resting arterial blood 
flow parameters in the current study, concurs with recent 
findings, that higher serum biomarkers of ω-3 consumption, 
may not impact on future blood pressure (43).
Conclusion
In summary, upper limb immobilisation resulted in 
a decrease in elbow isometric and isokinetic torque, with 
no observed effect on co-contraction, muscle fatigability or 
resting blood flow. We observed no significant effect of EPA 
or vitamin D supplementation on any of these parameters. 
Despite greater relative decreases in torque than in tissue 
composition (Part A), there is no significant effect of EPA or 
vitamin D supplementation on the decreases in torque. It would 
appear that muscle function might be a less sensitive marker 
of the effectiveness of a supplement against the impact of 
immobilisation than tissue composition.
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